Dexcom Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 07:15PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst

Hello, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Thanks for joining here before lunch. Happy to have our next company, Dexcom. I'm going to introduce the CEO, Kevin Sayer for a presentation, and then we'll do some Q&A after. Kevin?

Kevin Ronald Sayer - DexCom, Inc. - Executive Chairman, CEO & President

Thank you, Robbie, and thank you everyone for coming today.

For those of you who know me, I've been in the diabetes business since 1994. That's when I saw my first glucose sensor. It was hardwired and attached to something that looked like a crude high school basketball scoreboard and dipped in a beaker of glucose solution. It showed the number and I thought the technology was done. My little naive financial mind wasn't quite where it was supposed to be because it's taken a long time to get where we are today, but oh how things have changed. Back then all we wanted to do is display that data on a pump. Now we display that data on a phone and it goes to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot